Fig. 3: Validation of FGFR3-TACC3 gene fusion by Sanger sequencing.
From: Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma
a Nested RT-PCR was conducted using extracted RNA, and the available PCR product underwent Sanger sequencing. Two types of PCR products were generated after nested RT-PCR. b Sanger sequencing revealed gene fusion between FGFR3 (NM_000142 exon17) and TACC3 (NM_006342 exon11).
